PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME

PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME was reported 6 times

PSTPIP1-ASSOCIATED MYELOID-RELATED PROTEINAEMIA INFLAMMATORY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-1 Receptor Antagonist [EPC] 4 0.0002
1 CD52-directed Cytolytic Antibody [EPC] 4 0.0002
2 Interleukin-12 Antagonist [EPC] 4 0.0000
3 Interleukin-23 Antagonist [EPC] 4 0.0000
4 Leukocyte Growth Factor [EPC] 5 0.0000
5 Calcineurin Inhibitor Immunosuppressant [EPC] 4 0.0000
6 Interleukin-6 Receptor Antagonist [EPC] 4 0.0000
7 Alkylating Drug [EPC] 5 0.0000
8 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
9 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
10 Tumor Necrosis Factor Blocker [EPC] 4 0.0000
11 Corticosteroid [EPC] 1 0.0000